Anti-MRSA agent 14
Anti-MRSA agent 14 (Compound C17) exhibits antibacterial activity against MRSA and in a MRSA-infected mouse skin model. It demonstrates greater potential against MRSA compared to Norfloxacin. Anti-MRSA agent 14 disrupts cell membranes and inhibits metabolism. Its antibacterial MIC values against S. aureus ATCC 6538, S. aureus ATCC 29213, S. epidermidis ATCC 12228, and MRSA are 1, 2, 2, and 1 μM, respectively.
Product Specifications
CAS Number
3050586-22-3
Field of Research
Infectious Disease & Virology, Neuroscience
Smiles
C (NS (=O) (=O) C1=CC=C (Cl) C=C1) (=O) [C@]23[C@] (C=4[C@@] (C) (CC2) [C@@]5 (C) [C@] (CC4) ([C@]6 (C) [C@@] (CC5) (C (C) (C) C7=C (C6) C=8C (N7) =C (C (O) =O) C=CC8) [H]) [H]) (CC (C) (C) CC3) [H]
Molecular Formula
C43H53ClN2O5S
Molecular Weight
745.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
51188124 3x 1.0µg DNA
Zfp94 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Sign In for Pricing
View Details 22798116 3x 1.0 µg
Gtf2h4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details MBS6178695-01 0.1 mL
FANCG (Fanconi Anemia, Complementation Group G, FAG, XRCC9) (FITC)
Sign In for Pricing
View Details MBS6178695-02 5x 0.1 mL
FANCG (Fanconi Anemia, Complementation Group G, FAG, XRCC9) (FITC)
Sign In for Pricing
View Details 